Reply to thread

Message: [QUOTE="greenmedinfo, post: 4000"] PMID: PLoS One. 2021 ;16(9):e0256992. Epub 2021 Sep 2. PMID: 34473789 Abstract Title: Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis. Abstract: The efficacy of cranberry (Vaccinium spp.) as adjuvant therapy in preventing urinary tract infections (UTIs) remains controversial. This study aims to update and determine cranberry effects as adjuvant therapy on the recurrence rate of UTIs in susceptible groups. According to PRISMA guidelines, we conducted a literature search in Web of Science, PubMed, Embase, Scopus, and the Cochrane Library from their inception dates to June 2021. We included articles with data on the incidence of UTIs in susceptible populations using cranberry-containing products. We then conducted a trial sequential analysis to control the risk of type I and type II errors. This meta-analysis included 23 trials with 3979 participants. We found that cranberry-based products intake can significantly reduce the incidence of UTIs in susceptible populations (risk ratio (RR) = 0.70; 95% confidence interval(CI): 0.59 ~ 0.83; P [URL='https://www.greenmedinfo.com/article/consumption-cranberry-adjuvant-therapy-urinary-tract-infections-susceptible-po']read more[/URL] [/QUOTE]